Twist Bioscience holder plans $9.3M share sale
Security holder Emily M. Leproust files a Rule 144 notice to sell 61,509 TWST common shares, disclosing recent share issuances and prior sales.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) has a notice of proposed sale of restricted and other common shares under Rule 144 by security holder Emily M. Leproust. The filing indicates a proposed sale of 61,509 shares of common stock, with an aggregate market value of $9,314,307.87, and notes 62,707,424 shares of common stock outstanding. The notice also lists prior issuances to Leproust through restricted stock vesting and Employee Stock Purchase Plan purchases, as well as multiple common stock sales in recent months.
Positive
- None.
Negative
- None.
Key Figures
Proposed shares to be sold: 61,509 shares of common stock
Aggregate market value of proposed sale: $9,314,307.87
Shares outstanding: 62,707,424 shares
+5 more
8 metrics
Proposed shares to be sold
61,509 shares of common stock
Proposed Rule 144 sale by Emily M. Leproust
Aggregate market value of proposed sale
$9,314,307.87
Value associated with 61,509 shares proposed for sale
Shares outstanding
62,707,424 shares
Common stock outstanding referenced in the securities information section
Sale on August 10, 2026
113,318 shares; $14,183,062.19
Common stock sale by Emily M. Leproust disclosed in past 3 months
Sale on August 25, 2026
41,570 shares; $6,317,760.97
Common stock sale by Emily M. Leproust disclosed in past 3 months
Restricted stock vesting on November 5, 2024
9,004 shares
Common shares issued as compensation via restricted stock vesting
Restricted stock vesting on October 1, 2024
7,783 shares
Common shares issued as compensation via restricted stock vesting
ESPP purchase on February 19, 2021
187 shares
Employee Stock Purchase Plan purchase listed in securities to be sold
Key Terms
Rule 144, restricted stock vesting, ESPP Purchase, aggregate market value, +1 more
5 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Common | 01/04/2021 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
ESPP Purchase financial
"Common | 02/19/2021 | ESPP Purchase | Issuer"
aggregate market value financial
"Common | Fidelity Brokerage Services LLC ... | 61509 | 9314307.87 |"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
compensation financial
"295 | 01/04/2021 | Compensation Common | 01/24/2021"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Twist Bioscience Corp (TWST)?
The Form 144 discloses that Emily M. Leproust intends to sell 61,509 shares of Twist Bioscience Corp common stock under Rule 144, with an indicated aggregate market value of $9,314,307.87, and notes 62,707,424 shares of common stock outstanding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
